Ono Pharmaceutical Co., Ltd.
4528.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥204,567,000 | ¥166,141,000 | ¥96,135,000 | ¥69,112,000 |
| Short-Term Investments | ¥5,813,000 | ¥38,454,000 | ¥68,154,000 | ¥47,857,000 |
| Receivables | ¥135,022,000 | ¥136,066,000 | ¥114,396,000 | ¥99,788,000 |
| Inventory | ¥74,864,000 | ¥48,629,000 | ¥44,814,000 | ¥41,817,000 |
| Other Curr. Assets | ¥34,838,000 | ¥9,607,000 | ¥7,861,000 | ¥11,740,000 |
| Total Curr. Assets | ¥455,104,000 | ¥413,596,000 | ¥345,101,000 | ¥281,266,000 |
| Property Plant & Equip (Net) | ¥105,721,000 | ¥104,752,000 | ¥108,420,000 | ¥112,131,000 |
| Goodwill | ¥21,186,000 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥330,041,000 | ¥57,288,000 | ¥69,134,000 | ¥64,734,000 |
| Long-Term Investments | ¥96,502,000 | ¥297,170,000 | ¥252,710,000 | ¥252,456,000 |
| Tax Assets | ¥51,020,000 | ¥0 | ¥35,604,000 | ¥25,074,000 |
| Other NC Assets | ¥4,472,000 | ¥40,862,000 | ¥71,468,000 | ¥3,542,000 |
| Total NC Assets | ¥608,942,000 | ¥500,072,000 | ¥537,336,000 | ¥457,937,000 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥1,064,046,000 | ¥913,668,000 | ¥882,437,000 | ¥739,203,000 |
| Liabilities | – | – | – | – |
| Payables | ¥89,329,000 | ¥60,691,000 | ¥66,794,000 | ¥49,689,000 |
| Short-Term Debt | ¥30,000,000 | ¥2,310,000 | ¥2,490,000 | ¥2,301,000 |
| Tax Payable | ¥4,058,000 | ¥22,093,000 | ¥34,575,000 | ¥1,526,000 |
| Deferred Revenue | ¥0 | ¥22,093,000 | ¥35,236,000 | ¥2,242,000 |
| Other Curr. Liab. | ¥21,731,000 | -¥19,366,000 | -¥30,382,000 | -¥1,466,000 |
| Total Curr. Liab. | ¥148,296,000 | ¥103,624,000 | ¥122,929,000 | ¥65,926,000 |
| LT Debt | ¥105,000,000 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥10,817,000 | ¥1,013,000 | ¥983,000 | ¥1,009,000 |
| Other NC Liab. | ¥3,231,000 | ¥3,874,000 | ¥4,034,000 | ¥4,093,000 |
| Total NC Liab. | ¥127,548,000 | ¥11,439,000 | ¥11,695,000 | ¥11,603,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥11,678,000 | ¥8,862,000 | ¥9,168,000 | ¥8,802,000 |
| Total Liabilities | ¥275,844,000 | ¥115,063,000 | ¥134,624,000 | ¥77,529,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥17,358,000 | ¥17,358,000 | ¥17,358,000 | ¥17,358,000 |
| Retained Earnings | ¥790,908,000 | ¥768,183,000 | ¥709,890,000 | ¥644,754,000 |
| AOCI | ¥19,790,000 | ¥53,195,000 | ¥51,702,000 | ¥51,236,000 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥782,451,000 | ¥792,961,000 | ¥741,869,000 | ¥655,906,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥5,751,000 | ¥5,644,000 | ¥5,944,000 | ¥5,768,000 |
| Total Liab. & Tot. Equity | ¥1,064,046,000 | ¥913,668,000 | ¥882,437,000 | ¥739,203,000 |
| Net Debt | -¥69,567,000 | -¥163,831,000 | -¥93,645,000 | -¥66,811,000 |